Phoenix, AZ, United States of America

David Barclay

This inventor holds 1 USPTO granted patent. Top assignee: 10X Genomics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Barclay. Retrieved from https://idiyas.com/inventor/david-barclay-9s7i9p6t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Barclay: Innovator in Nucleic Acid Detection

Introduction

David Barclay is a notable inventor based in Phoenix, AZ. He has made significant contributions to the field of biological sample analysis, particularly in the detection of nucleic acid sequences. His innovative work has led to the development of methods and systems that enhance the accuracy and efficiency of analyte detection.

Latest Patents

David Barclay holds a patent for "Compositions and methods for analyte detection." This patent provides methods, systems, and compositions for detecting nucleic acid sequences in a biological sample that has a three-dimensional matrix. Additionally, it outlines processes for preparing biological samples for nucleic acid sequence detection.

Career Highlights

David is currently employed at 10X Genomics, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions that improve genomic analysis and diagnostics.

Collaborations

David collaborates with talented individuals in his field, including coworkers Evan Daugharthy and Tyler Miselis. Their combined expertise contributes to the success of their projects and the advancement of technology in nucleic acid detection.

Conclusion

David Barclay is a dedicated inventor whose work in nucleic acid detection has the potential to impact various fields, including medicine and biotechnology. His contributions are paving the way for more effective diagnostic methods and enhancing our understanding of biological samples.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…